[Regenerative medicine in diabetes by beta cell therapy and promotion of beta cell growth and differentiation].
Miyagawa
Jun-ichiro
J
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
D000818:Animals; D000951:Antigens, Neoplasm; D066259:Betacellulin; D014408:Biomarkers, Tumor; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics; D002455:Cell Division / Q000187:drug effects / Q000235:genetics; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D015316:Genetic Therapy; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation; D037181:Lectins, C-Type; D009536:Niacinamide / Q000494:pharmacology / Q000627:therapeutic use; D000073718:Pancreatitis-Associated Proteins; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D011498:Protein Precursors / Q000494:pharmacology / Q000627:therapeutic use; D011506:Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012038:Regeneration / Q000502:physiology*; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology*; D023822:Tissue Engineering
D000951:Antigens, Neoplasm; C587851:BTC protein, human; D066259:Betacellulin; D014408:Biomarkers, Tumor; D036341:Intercellular Signaling Peptides and Proteins; D037181:Lectins, C-Type; D000073718:Pancreatitis-Associated Proteins; D010446:Peptide Fragments; D011498:Protein Precursors; D011506:Proteins; C000612141:REG3A protein, human; D009536:Niacinamide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon